CASI Pharmaceuticals, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- EntreMed
- Miikana Therapeutics
Latest on CASI Pharmaceuticals, Inc.
At Swedish biotech BioInvent , early-stage data on two anti-tumor necrosis factor receptor 2 (TNFR2) antibodies are starting to show promise. Presenting at the annual Society for Immunotherapy for Ca
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Citeline's Biomedtracker. Lotus Licenses Corium’s Alzh
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis And Ionis Build On Earlier Akc
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biolojic To Use Computational Platform